Social engineering. CEO fraud of 9 million euros in the phishing scam to the biopharmaceutical company Zendal
A hacker has stolen more than 9 million euros from the Zendal pharmaceutical company in Galicia, Spain, by posing as a manager in a CEO fraud scheme. This impersonation allowed the attacker to make multiple bank transfers in his own name.

Hacker Steals €9 Million from Spanish Pharmaceutical Company via CEO Fraud
Incident Overview
A hacker has scammed more than €9 million from the Zendal pharmaceutical group in Galicia, Spain, using a CEO Fraud scheme. The attacker posed as a senior manager to authorize multiple bank transfers in his own name.
Attack Method
- Technique: Phishing with forged sender identity.
- The hacker impersonated a top executive to deceive the CFO into making several transfers.
- The scam went unnoticed until the company began to experience liquidity issues.
- Upon contacting the real manager, the CFO discovered the transfers had never been authorized.
Context
- Zendal is one of Spain’s leading biotechnology companies, currently preparing to produce hundreds of millions of COVID-19 vaccine doses.
- The company has filed a complaint with the Civil Guard, and investigations are underway to trace the money and identify those responsible.
- Zendal has stated that it will not make further public comments until the investigation concludes and will continue work on vaccine production.
Impact
This incident highlights how social engineering — particularly CEO Fraud — can cause devastating financial losses even in large, well-established organizations.
Key Takeaway
It is essential to train employees on the multiple forms of social engineering attacks and ensure strong verification processes for financial transactions.